The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey.
Forty-one of 49 (84%) patients with Behçet's disease in Turkey carried HLA-B5 (positive B5). Forty of the same 49 (82%) patients had a nonspecific skin hyperreactivity to needle prick (positive pathergy). There were no patients in whom both of these tests were negative.
D000328:Adult; D001528:Behcet Syndrome / Q000175:diagnosis* / Q000235:genetics; D005260:Female; D006680:HLA Antigens / Q000032:analysis / Q000145:classification*; D006801:Humans; D006967:Hypersensitivity / Q000175:diagnosis; D007428:Intradermal Tests; D008297:Male; D012698:Serologic Tests; D012882:Skin Tests; D014421:Turkey
D006680:HLA Antigens